Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

PACS Group Sees FY24 Revenue $3.85B-$3.95B Vs $3.76B Est.

Author: Benzinga Newsdesk | August 12, 2024 04:12pm

Business Outlook

Based on information available as of today, PACS is providing the following guidance for full year 2024:

  • Revenue expected to be in the range of $3.85 billion to $3.95 billion
  • Adjusted EBITDA expected to be in the range of $370 million to $380 million

As of today, PACS's growing portfolio consists of 248 healthcare operations, 30 of which also include senior living operations, across 13 states. PACS owns 87 real estate assets with purchase options on an additional 31 real estate assets, including both wholly owned and owned in a joint venture. The Company's overall strategy continues to include both leasing and acquiring real estate and the Company continues to actively consider opportunities to acquire both performing and underperforming operations in several states.

Posted In: PACS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist